Literature DB >> 8871672

The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity.

C L Keech1, T P Gordon, J McCluskey.   

Abstract

Clustering of autoantibody specificities is a consistent finding in patients with systemic autoimmune diseases. Patients with Sjögren's syndrome frequently have autoantibodies to La, 60-kDa Ro(SS-A) protein (Ro60), and 52-kDa Ro(SS-A) protein (Ro52). In the case of anti-Ro60 and anti-La, there is evidence that these specificities occur together because of the physical association of the Ro60 and La proteins that form a ribonucleoprotein particle (RNP). Thus, the autoantibody response may spread from a single epitope to involve new epitopes located within other components of the RNP. The physical association of Ro52 with the Ro/La RNP has remained controversial, implying that Abs to Ro52 are not a consequence of intermolecular spreading and may be triggered independently of the anti-Ro60 response. To examine this relationship of the immune response to Ro52 and Ro60, mice were immunized with recombinant Ro52, Ro60, or La, and examined for autoantibody production. Immunization with Ro52 resulted in rapid, high titer Ab production to Ro52, followed 7 to 14 days later by lower titer autoantibody production to Ro60. Immunization with Ro60 led to anti-Ro60, which was also followed 7 to 14 days later by a lower titer anti-Ro52 response. Cross-reactivity of affinity-purified Abs from immune mouse sera was not observed. These observations suggest that the autoimmune responses to Ro60 and Ro52 are linked intrinsically, despite previous evidence suggesting they are not associated in vivo. The mechanism of linkage remains unclear, but the data are most consistent with some physical association of Ro52 and Ro60 allowing autoimmunization, presumably as a result of normal cell turnover or specific injury in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871672

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Spreading of antibody reactivity to non-thyroid antigens during experimental immunization with human thyroglobulin.

Authors:  A Thrasyvoulides; E Liakata; P Lymberi
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 2.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 3.  Stress protein-polypeptide complexes acting as autoimmune triggers.

Authors:  P Eggleton
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

4.  Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice.

Authors:  G Kinoshita; A W Purcell; C L Keech; A D Farris; J McCluskey; T P Gordon
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

5.  Defining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies.

Authors:  D Wang; J P Buyon; W Zhu; E K Chan
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Heterogeneity of human Ro ribonucleoproteins (RNPS): nuclear retention of Ro RNPS containing the human hY5 RNA in human and mouse cells.

Authors:  M Gendron; D Roberge; G Boire
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

7.  HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS).

Authors:  M Rischmueller; S Lester; Z Chen; G Champion; R Van Den Berg; R Beer; T Coates; J McCluskey; T Gordon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

8.  Immune response against the coiled coil domain of Sjögren's syndrome associated autoantigen Ro52 induces salivary gland dysfunction.

Authors:  Magdalena Sroka; Harini Bagavant; Indranil Biswas; Abigail Ballard; Umesh S Deshmukh
Journal:  Clin Exp Rheumatol       Date:  2018-01-31       Impact factor: 4.473

Review 9.  Neonatal lupus: clinical features, therapy, and pathogenesis.

Authors:  L A Lee
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

10.  Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes.

Authors:  J H Reed; P J Neufing; M W Jackson; R M Clancy; P J Macardle; J P Buyon; T P Gordon
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.